欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33861 篇 当前为第 3332 页 共 3387

所属行业:医药制造业

  • 33311.国家中医药局大力推进中医药文化建设

    [医药制造业] [2013-09-27]

    关键词:中医药局;中医药;文化建设
  • 33312.国产完全可降解支架与国际同步

    [医药制造业] [2013-09-27]

    关键词:可降解支架;国际前沿
  • 33313.全球手性技术市场报告(2012-2016年)

    [医药制造业] [2013-09-27]

    The phenomenon by which molecules do not superimpose with their mirror images is termed as chirality, and such molecules are called chiral molecules. The importance of chiral drugs has long been recognized by pharmaceutical companies as a means to mitigate side effects in patients. Many drugs that possess chiral characteristics are administered as racemates despite the fact that the optical isomers of racemic drugs can exhibit different pharmacological profiles in the human body. Chiral technologies are used to synthesize, analyze, and separate out the enantiomers from a racemic mixture. In particular, they help in the development of the enantiopure form of a drug to produce the required effect.The growth of the Global Chiral Technology market is driven by several factors. Governmental regulations that support the use of chiral technology constitute a major driver in this market. Healthcare authorities in many countries have introduced guidelines and policies that provide incentives for investments made in developing single enantiomer drugs. Further, there is a growing demand for enantiopure drugs.
    关键词:手性分子;手性技术;手性药物;制药;外消旋体
  • 33314.新兴产业周刊——2013年36期

    [水利、环境和公共设施管理业,电力、热力、燃气及水生产和供应业,信息传输、软件和信息技术服务业,专用设备制造业,医药制造业,综合,通用设备制造业] [2013-09-27]

    本刊以七大战略性新兴产业——节能环保、新一代信息技术、生物、高端装备制造、新能源、新材料、新能源汽车为研究重点,关注国家高层和各部委的动态,剖析国家和地方的新兴产业政策。本刊设有政策导读、领导讲话、七大战略性新兴产业本周国内外行业动态和重点企业新闻、投资专题四大板块,能够实时监测新兴产业和重点企业动态,把握新兴产业发展方向,研究发展重点,寻求发展机遇。
    关键词:节能环保;新一代信息技术;生物;高端装备制造;新能源;新材料;新能源汽车
  • 33315.广东药品招标新规则尘埃落定250亿元药品市场洗牌在即

    [医药制造业] [2013-09-27]

    关键词:药品招标;招标新规;药品市场
  • 33316.全球肾上腺素自动注射器市场报告(2012-2016年)

    [医药制造业] [2013-09-27]

    The growth of the Global Epinephrine Auto-injector market is driven by several factors. One of the major drivers in this market is the increase in the prevalence of people suffering from allergies. The increase in the number of people that are allergic to food, food additives, dust, and insect venom has led to growth in the usage of epinephrine drugs. People in developed countries are not exposed to allergens because of their modern lifestyles. As a result, their immune systems are not able to immunize themselves from the allergen attacks. Another major driver in the market is the increased use of epinephrine drugs for the treatment of cardiac arrest caused as a result of anaphylactic shock. Epinephrine drugs prevent the cardiac arrest by quickly stimulating the heart, increasing the blood pressure, relaxing the involuntary muscles, and constricting small blood vessels. Thus, epinephrine drugs are increasingly used as an emergency treatment for cardiac arrest..
    关键词:肾上腺素;注射剂型;自动注射器
  • 33317.全球多发性硬化症(MS)治疗市场报告(2012-2016年)

    [医药制造业] [2013-09-26]

    The Global MS market is expected to grow at a steady pace during the period 2012-2016. In 2012, the market was dominated by the Americas, which was followed by the EMEA region and the APAC region. At present, the major portion of the market growth is derived from sales of the best-selling drug, Biogen's Avonex, which is used to treat relapsing forms of MS. Currently, there is no therapy that cures MS completely. Nevertheless, there are a number of therapies that may aid in mitigating the disease by reducing the severity of attacks as well as their frequency. Owing to the low treatment-seeking rate, the low diagnosis rate, and the availability of alternate options, the Global MS market is expected to grow at a steady pace during the forecast period. The new entrants that are expected to enter the market during the forecast period might capture a significant share in the market as the pipeline drugs focus on disease progression. The Global MS market is expected to grow at a CAGR of 3.16 percent during the forecast period.
    关键词:多发性硬化症(MS);强管道药物分子;中枢神经系统;遗传;环境因素
  • 33318.全球灰指甲治疗市场报告(2012-2016年)

    [医药制造业] [2013-09-26]

    This report covers the present scenario and the growth prospects of the Global Dermatophytic Onychomycosis Therapeutics market for the period 2012-2016. It also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the market. To calculate the market size, the report considers revenue generated from the sales of various therapies such as topical treatment products and systemic therapy products used in the treatment of dermatophytic onychomycosis. In addition, the report discusses the major drivers that influence the growth of the Global Dermatophytic Onychomycosis Therapeutics market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
    关键词:灰指甲治疗;真菌病治疗;市场规模;甲癣;局部治疗;全身治疗
  • 33319.[国研专稿]2013年上半年医药行业回顾与展望

    [医药制造业] [2013-09-25]

    2013年上半年,医药行业产销增速未有明显改善,且偿债能力略有下降,但盈利能力总体稳定。从横向比较来看,医药行业生产增速在全国12个工业门类中增速最快,获利能力在制造业中保持领先地位,债务负担相对较轻,行业的弱周期性和成长性均得到较明显体现。2013年下半年,在积极有序的产业政策环境下,消费杠杆刺激及有效市场需求扩大将带动医药行业保持较高景气度,产销指标转好的预期增强,盈利能力将有提升或超预期的可能,行业依然具备明显的比较优势,但企业需警惕销售费用增长过快的局面。
    关键词:医药行业;回顾与展望
  • 33320.2013年9月(上半月)医药行业要闻综述

    [医药制造业] [2013-09-25]

    本文内容为2013年9月(上半月)医药行业要闻综述,主要内容包括:政策监管、行业要闻、区域要闻、企业要闻和海外要闻,并对其中部分重要新闻加以简要点评。
    关键词:医药行业;行业要闻;企业要闻;区域要闻;海外要闻
首页  上一页  ...  3327  3328  3329  3330  3331  3332  3333  3334  3335  3336  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服